One clinical trial of Opdivo involved adults with squamous non-small cell lung cancer (NSCLC). Researchers found that people with squamous NSCLC who took Opdivo had a lower risk of death compared ...

Retevmo (selpercatinib) is a medicine that is used in adults for certain types of non-small-cell lung cancer (NSCLC ... with you about how long you can expect to take Retevmo.

In the Phase III DeLLphi-304 trial, patients with small cell lung cancer administered ... 1 According to the American Cancer Society, lung cancer remains the leading cause of cancer-related death in ...

A pill has been shown to halve the risk of death from a certain type of lung ... size-fits-all treatment for people with non-small cell lung cancer." Osimertinib is already authorised in dozens ...

OmRx Oncology (OmRx) has commenced a Phase II trial for its OX-4224, targeting individuals with non-small cell lung cancer ...

Researchers have shown that activation of the protein YAP, known to help cancer cells survive treatment, behaves very differently in cell culture models depending on how they are grown in the lab, ...

The drug has been specifically authorised in combination with etoposide and platinum chemotherapy to treat adult patients with extensive-stage small cell lung cancer (SCLC ... in a 25% reduction in ...

TTFields exert physical forces on the electrically charged components of dividing cancer cells, resulting in cell death. “The CE Mark approval for Optune Lua for metastatic non-small cell lung ...